Feature 2

COVID-19 Information

March 17, 2020

In light of the recent COVID-19 (Coronavirus) pandemic, many people naturally have questions about how this may affect them. Many of you may have recently received an email from National PKU Alliance (NPKUA) containing some very helpful information … (read more)


BioMarin’s “PegPal” Receives FDA Approval

May 26, 2018

BioMarin announced this week that the FDA has approved its Palynziq™ injection for treatment of adults with Phenylketonuria (PKU). Formerly known during the clinical trials as PegPal, this is the first enzyme therapy to treat PKU and has been demonstrated … (read more)